ArticleScientific reports2026
Integrative genomic, transcriptomic, and metabolomic profiling of Dillenia suffruticosa.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The genus Dillenia, a basal core eudicot native to Southeast Asia and the Indian Ocean islands, is prized for its wide-ranging medicinal and ornamental applications. This study generated and integrated a chromosome-scale reference genome for D. suffruticosa spanning 599 Mb with 26 chromosomes (N50:24.1 Mb) encoding 28,248 genes using organ-resolved transcriptomics and untargeted metabolomic analysis. The root metabolome is dominated by triterpenoids, including lupeol, α-/β-amyrin, and betulinic acid, whose abundance mirrors a selective cytotoxic profile against a panel of 10 cancer cell lines. Ethanol extracts were active against 7 of 10 lines (IC₅₀ = 92-194 µg mL⁻¹), while SFE extracts were active against 6 lines (IC₅₀ = 91-234 µg mL⁻¹), with limited or no activity observed in the remaining lines (IC₅₀ > 300 µg mL⁻¹). Although the specific bioactive compound(s) remain unresolved, genome annotation identified candidate oxidosqualene cyclases and downstream putative cytochrome P450 monooxygenases and UDP-glycosyltransferases, indicating the presence of genes associated with triterpenoid biosynthesis. Together, these chemogenomic resources illuminate the molecular basis of specialized metabolism in D. suffruticosa and establish a platform for future studies on its ecological functions and the discovery of plant-derived therapeutic candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.